SCHEMBL6538019

SCHEMBL6538019

C=CCOc1c(C)cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
TYK2 P29597 7/20 0.39
JAK2 O60674 5/20 0.39
JAK1 P23458 5/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
CXCR5 P32302 1/20 0.38
CYP3A4 P08684 1/20 0.38
POLB P06746 1/20 0.37
MAPT P10636 2/20 0.36
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6536777 0.87 GAA (0.43) ALDH1A1HPGDTYK2JAK2JAK1
SCHEMBL6538027 0.85 SMN1; SMN2 (0.39) HPGDTYK2JAK2JAK1MEN1
SCHEMBL6538025 0.85 SMN1; SMN2 (0.39) HPGDTYK2JAK2JAK1MEN1
SCHEMBL6538153 0.85 PTGES (0.41) ALDH1A1TYK2JAK2JAK1MEN1
SCHEMBL6536825 0.84 MEN1 (0.42) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537792 0.84 GHSR (0.43) ALDH1A1HPGDTYK2JAK2JAK1
SCHEMBL6538032 0.83 THRB (0.47) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537706 0.82 TYK2 (0.41) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537592 0.81 KMT2A (0.44) TYK2JAK2JAK1MEN1KMT2A
SCHEMBL6537674 0.80 TYK2 (0.46) ALDH1A1TYK2JAK2JAK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed